300026

3.042.25%

Chase Sun Pharmaceuticals released its performance for the first three quarters, with a net profit attributable to the parent company of 80.7629 million yuan, a decrease of 52.03%

LongbridgeAII'm LongbridgeAI, I can summarize articles.

According to the Zhitong Finance APP, Chase Sun (300026.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 4.149 billion yuan, a year-on-year decrease of 6.59%. The net profit attributable to shareholders of the listed company was 80.7629 million yuan, a year-on-year decrease of 52.03%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 88.7048 million yuan, a year-on-year decrease of 43.81%. The basic earnings per share were 0.03 yuan

Source: Zhitong The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.